Michael Fastenberg, MD in Smithtown, NY - Medicare Dermatology

Michael Fastenberg, MD is a medicare enrolled "Dermatology" physician in Smithtown, New York. He went to State University Of New York At Stony Brook, School Of Medicine and graduated in 2005 and has 19 years of diverse experience with area of expertise as Dermatology. He is a member of the group practice Schweiger Dermatology Pllc and his current practice location is 260 Middle Country Rd, Suite 208, Smithtown, New York. You can reach out to his office (for appointments etc.) via phone at (631) 863-3223.

Michael Fastenberg is licensed to practice in New York (license number 252150-1) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1073735593.

Contact Information

	Michael Fastenberg, MD
	260 Middle Country Rd, Suite 208, Smithtown, NY 11787-2982
	(631) 863-3223
	(631) 863-3334

Physician's Profile

Full Name	Michael Fastenberg
Gender	Male
Speciality	Dermatology
Experience	19 Years
Location	260 Middle Country Rd, Smithtown, New York
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Michael Fastenberg attended and graduated from State University Of New York At Stony Brook, School Of Medicine in 2005

NPI Data:

NPI Number: 1073735593
Provider Enumeration Date: 05/03/2007
Last Update Date: 01/26/2011

Medicare PECOS Information:

PECOS PAC ID: 0648325050
Enrollment ID: I20090909000436

Medical Identifiers

Medical identifiers for Michael Fastenberg such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1073735593	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	2006-01943 (North Carolina)	Secondary
207N00000X	Dermatology	252150-1 (New York)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Schweiger Dermatology Pllc	5991947160	178

News Archive

EMA COMP grants orphan medicinal product designation for Raptor's DR Cysteamine for cystinosis

Raptor Pharmaceutical Corp., announced that the European Medicines Agency's ("EMA") Committee for Orphan Medicinal Products ("COMP") has issued a positive opinion recommending orphan medicinal product designation for DR Cysteamine for the potential treatment of cystinosis.

Provena Health and Resurrection Health Care are now joined as Presence Health

Presence Health has been chosen as the name of the new healthcare system formed by the November 2011 merger of Provena Health of Mokena, IL, and Resurrection Health Care of Chicago, IL. A formal rollout of a new logo and related branding will occur over the next several months.

Structural imaging techniques can help identify risk for developing Alzheimer's disease

New results from a study by neuroscientists at Rush University Medical Center suggest that people at risk of developing Alzheimer's disease exhibit a specific structural change in the brain that can be visualized by brain imaging. The findings may help identify those who would most benefit from early intervention.

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

BioDelivery Sciences International, Inc. announced today the enrollment of the first patient in the RHAPSODY Study, a Phase 3 clinical trial of Clonidine Topical Gel for the treatment of painful diabetic neuropathy.

VentriPoint Diagnostics to present abstract on VMS clinical validation study

VentriPoint Diagnostics Ltd. today announced the abstract of a clinical validation study of the second application of the VentriPoint Medical System (VMS) will be presented at the American College of Cardiology's 59th Annual Scientific Session, March 14 to 16 in Atlanta, Georgia. The study demonstrates the accuracy of the method used by the VentriPoint Medical System (VMS) to generate critical heart measurements in three dimensions from two-dimensional ultrasound images with significantly greater speed and accuracy and at considerably lesser cost than is otherwise possible.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Michael Fastenberg allows following entities to bill medicare on his behalf.

Entity Name	Schweiger Dermatology Pllc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1831438662 PECOS PAC ID: 5991947160 Enrollment ID: O20130819000251

News Archive

EMA COMP grants orphan medicinal product designation for Raptor's DR Cysteamine for cystinosis

Provena Health and Resurrection Health Care are now joined as Presence Health

Structural imaging techniques can help identify risk for developing Alzheimer's disease

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

VentriPoint Diagnostics to present abstract on VMS clinical validation study

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michael Fastenberg is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Michael Fastenberg, MD 260 Middle Country Rd, Suite 208, Smithtown, NY 11787-2982 Ph: (631) 863-3223	Michael Fastenberg, MD 260 Middle Country Rd, Suite 208, Smithtown, NY 11787-2982 Ph: (631) 863-3223

News Archive

EMA COMP grants orphan medicinal product designation for Raptor's DR Cysteamine for cystinosis

Provena Health and Resurrection Health Care are now joined as Presence Health

Structural imaging techniques can help identify risk for developing Alzheimer's disease

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

VentriPoint Diagnostics to present abstract on VMS clinical validation study

Dermatology Doctors in Smithtown, NY

Ms. Tamara Koss, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 260 Middle Country Rd, Suite 208, Smithtown, NY 11787 Phone: 631-863-3223 Fax: 631-863-3334
Faith Leslie Leffel, RPA C Dermatology Medicare: Medicare Enrolled Practice Location: 327 E Main St, Smithtown, NY 11787 Phone: 631-979-0909 Fax: 631-979-0455
Dr. Donna April Serure, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 327 E Main St, Smithtown, NY 11787 Phone: 631-979-0909 Fax: 631-979-0455
Dr. Snehal P Amin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 327 Middle Country Rd, Smithtown, NY 11787 Phone: 631-979-0909 Fax: 631-979-0455
Dr. Audra Marie Malerba, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 327 E Main St, Smithtown, NY 11787 Phone: 631-979-0909 Fax: 631-979-0455
Lawrence Martin Lieblich, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9 Brooksite Dr, Smithtown, NY 11787 Phone: 631-390-7800 Fax: 631-390-7821

Michael Fastenberg, MD - Medicare Dermatology in Smithtown, NY

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

EMA COMP grants orphan medicinal product designation for Raptor's DR Cysteamine for cystinosis

Provena Health and Resurrection Health Care are now joined as Presence Health

Structural imaging techniques can help identify risk for developing Alzheimer's disease

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

VentriPoint Diagnostics to present abstract on VMS clinical validation study

Medicare Reassignments

EMA COMP grants orphan medicinal product designation for Raptor's DR Cysteamine for cystinosis

Provena Health and Resurrection Health Care are now joined as Presence Health

Structural imaging techniques can help identify risk for developing Alzheimer's disease

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

VentriPoint Diagnostics to present abstract on VMS clinical validation study

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

EMA COMP grants orphan medicinal product designation for Raptor's DR Cysteamine for cystinosis

Provena Health and Resurrection Health Care are now joined as Presence Health

Structural imaging techniques can help identify risk for developing Alzheimer's disease

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

VentriPoint Diagnostics to present abstract on VMS clinical validation study

Dermatology Doctors in Smithtown, NY